Intracarotid transplantation of autologous adipose-derived mesenchymal stem cells significantly improves neurological deficits in rats after MCAo

Journal of Materials Science: Materials in Medicine

Volumn 25, Issue 5, 2014, Pages 1357-1366

  Jiang, Wei ^a   Liang, Guobiao ^a   Li, Xiaoming ^a   Li, Zhiqing ^a   Gao, Xu ^a   Feng, Sizhe ^a   Wang, Xiaogang ^a   Liu, Minpei ^a   Liu, Yang ^a  

^a GENERAL HOSPITAL OF NORTHERN THEATER COMMAND   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELL DEATH; CELL PROLIFERATION; NEUROLOGY; RATS;

ACUTE ISCHEMIC STROKE; ADIPOSE-DERIVED MESENCHYMAL STEM CELLS; CELLULAR PROLIFERATIONS; GLIAL FIBRILLARY ACIDIC PROTEINS; ISCHEMIA/REPERFUSION; MIDDLE CEREBRAL ARTERY OCCLUSIONS; PATHOLOGICAL CHANGES; THERAPEUTIC APPLICATION;

STEM CELLS;

GLIAL FIBRILLARY ACIDIC PROTEIN; NEURON SPECIFIC NUCLEAR PROTEIN; SODIUM CHLORIDE;

ADHESIVE REMOVAL SOMATOSENSORY TEST; ADIPOSE DERIVED MESENCHYMAL STEM CELL TRANSPLANTATION; ADIPOSE DERIVED STEM CELL; ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOTRANSPLANTATION; BEHAVIOR ASSESSMENT; BRAIN FUNCTION; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN SIZE; CAROTID ARTERY; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CLINICAL EVALUATION; COMPARATIVE STUDY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EXPERIMENTAL BEHAVIORAL TEST; HISTOPATHOLOGY; IMMUNOFLUORESCENCE; MACROGLIA; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MIDDLE CEREBRAL ARTERY OCCLUSION; MODIFIED NEUROLOGIC SEVERITY SCORE; NEUROLOGIC DISEASE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SPRAGUE DAWLEY RAT; STAINING; TUNEL ASSAY; ADIPOCYTE; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; INFARCTION, MIDDLE CEREBRAL ARTERY; INTERNAL CAROTID ARTERY; MESENCHYMAL STROMA CELL; NERVE CELL; NERVOUS SYSTEM DISEASES; PATHOLOGY; PROCEDURES; SURGERY; TREATMENT OUTCOME;

ADIPOCYTES; ANIMALS; CAROTID ARTERY, INTERNAL; CELL DIFFERENTIATION; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; NERVOUS SYSTEM DISEASES; NEURONS; RATS; RATS, SPRAGUE-DAWLEY; TREATMENT OUTCOME;

EID: 84921922862     PISSN: 09574530     EISSN: 15734838     Source Type: Journal    
DOI: 10.1007/s10856-014-5157-9     Document Type: Article

References (32)

1. Feigin VL, Lawes CM, Bennett DA, Anderson CS. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol. 2003;2(1):43–53.
2. Wardlaw JM, Murray V, Berge E, Del Zoppo GJ. Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev. 2009;7(4):CD000213.
3. Bravata DM. Intravenous thrombolysis in acute ischaemic stroke. CNS Drugs. 2005;19(4):295–302.
4. Ginsberg MD. Neuroprotection for ischemic stroke: past, present and future. Neuropharmacology. 2008;55(3):363–89.
5. Goldstein LB, Rothwell PM. Advances in prevention and health services delivery 2009. Stroke. 2010;41(2):e71–3.
6. Bacigaluppi M, Pluchino S, Martino G, Kilic E, Hermann DM. Neural stem/precursor cells for the treatment of ischemic stroke. J Neurol Sci. 2008;265(1):73–7.
7. Abbott JD, Giordano FJ. Stem cells and cardiovascular disease. J Nucl Cardiol. 2003;10(4):403–12.
8. Woodbury D, Schwarz EJ, Prockop DJ, Black IB. Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res. 2000;61(4):364–70.
9. Suzuki K, Oyama M, Faulcon L, Robbins P, Niyibizi C. In vivo expression of human growth hormone by genetically modified murine bone marrow stromal cells and its effect on the cells in vitro. Cell Transpl. 2000;9(3):319.
10. Li Y, Chopp M, Chen J, Wang L, Gautam SC, Xu Y-X, et al. Intrastriatal transplantation of bone marrow nonhematopoietic cells improves functional recovery after stroke in adult mice. J Cereb Blood Flow Metab. 2000;20(9):1311–9.
11. Zhao L-R, Duan W-M, Reyes M, Keene CD, Verfaillie CM, Low WC. Human bone marrow stem cells exhibit neural phenotypes and ameliorate neurological deficits after grafting into the ischemic brain of rats. Exp Neurol. 2002;174(1):11–20.
12. Pansky A, Roitzheim B, Tobiasch E. Differentiation potential of adult human mesenchymal stem cells. Clin Lab. 2007;53(1–2):81.
13. Safford KM, Hicok KC, Safford SD, Halvorsen Y-DC, Wilkison WO, Gimble JM, et al. Neurogenic differentiation of murine and human adipose-derived stromal cells. Biochem Biophys Res Commun. 2002;294(2):371–9.
14. Fujimura J, Ogawa R, Mizuno H, Fukunaga Y, Suzuki H. Neural differentiation of adipose-derived stem cells isolated from GFP transgenic mice. Biochem Biophys Res Commun. 2005;333(1):116–21.
15. Kang SK, Lee DH, Bae YC, Kim HK, Baik SY, Jung JS. Improvement of neurological deficits by intracerebral transplantation of human adipose tissue-derived stromal cells after cerebral ischemia in rats. Exp Neurol. 2003;183(2):355–66.
16. Leu S, Lin Y-C, Yuen C-M, Yen C-H, Kao Y-H, Sun C-K, et al. Adipose-derived mesenchymal stem cells markedly attenuate brain infarct size and improve neurological function in rats. J Translat Med. 2010;8(1):63.
17. Li Y, Chen J, Wang L, Lu M, Chopp M. Treatment of stroke in rat with intracarotid administration of marrow stromal cells. Neurology. 2001;56(12):1666–72.
18. Lu D, Li Y, Wang L, Chen J, Mahmood A, Chopp M. Intraarterial administration of marrow stromal cells in a rat model of traumatic brain injury. J Neurotrauma. 2001;18(8):813–9.
19. Kamiya N, Ueda M, Igarashi H, Nishiyama Y, Suda S, Inaba T, et al. Intra-arterial transplantation of bone marrow mononuclear cells immediately after reperfusion decreases brain injury after focal ischemia in rats. Life Sci. 2008;83(11):433–7.
20. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7(2):211–28.
21. Longa EZ, Weinstein PR, Carlson S, Cummins R. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 1989;20(1):84–91.
22. Chen J, Li Y, Wang L, Zhang Z, Lu D, Lu M, et al. Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats. Stroke. 2001;32(4):1005–11.
23. Schallert T, Kozlowski DA, Humm JL, Cocke RR. Use-dependent structural events in recovery of function. Adv Neurol. 1997;73:229.
24. Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson C, Sharp FR. A Semiautomated Method for Measuring BrainInfarct Volume. J Cereb Blood Flow Metab. 1990;10(2):290–3.
25. Chavakis E, Urbich C, Dimmeler S. Homing and engraftment of progenitor cells: a prerequisite for cell therapy. J Mol Cell Cardiol. 2008;45(4):514–22.
26. Shen LH, Li Y, Chen J, Zacharek A, Gao Q, Kapke A, et al. Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke. J Cereb Blood Flow Metab. 2006;27(1):6–13.
27. Mckeon RJ, Höke A, Silver J. Injury-induced proteoglycans inhibit the potential for laminin-mediated axon growth on astrocytic scars. Exp Neurol. 1995;136(1):32–43.
28. Pavlichenko N, Sokolova I, Vijde S, Shvedova E, Alexandrov G, Krouglyakov P, et al. Mesenchymal stem cells transplantation could be beneficial for treatment of experimental ischemic stroke in rats. Brain Res. 2008;1233:203–13.
29. Ginsberg MD, Pulsinelli WA. The ischemic penumbra, injury thresholds, and the therapeutic window for acute stroke. Annals of neurology. 1994;36(4):553–4.
30. Xing B, Chen H, Zhang M, Zhao D, Jiang R, Liu X, et al. Ischemic postconditioning inhibits apoptosis after focal cerebral ischemia/reperfusion injury in the rat. Stroke. 2008;39(8):2362–9.
31. Li D, Fang Y, Wang P, Shan W, Zuo Z, Xie L. Autologous transplantation of adipose-derived mesenchymal stem cells attenuates cerebral ischemia and reperfusion injury through suppressing apoptosis and inducible nitric oxide synthase. Int J Mol Med. 2012;29(5):848.
32. Castro RF, Jackson KA, Goodell MA, Robertson CS, Liu H, Shine HD. Failure of bone marrow cells to transdifferentiate into neural cells in vivo. Science. 2002;297(5585):1299.